ARCHIVES

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986

In Brief: Hutchinson Awarded $8 Million Grant For Pancreatic, Colorectal Cancer Studies

September 18, 1998

SBIR Solicitation Issued

September 13, 1996

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008

Study Underway To Help Childhood Cancer Survivors With Learning Difficulties

October 26, 2001